ALSN(ALSN)
ALSN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $5.82B | $6.08B | $6.44B |
| Low | $5.73B | $6.02B | $6.30B |
| High | $5.92B | $6.18B | $6.67B |
| EBITDA Avg | $2.01B | $2.09B | $2.22B |
| Low | $1.97B | $2.07B | $2.17B |
| High | $2.04B | $2.13B | $2.30B |
| EBIT Avg | $1.90B | $1.99B | $2.11B |
| Low | $1.87B | $1.97B | $2.06B |
| High | $1.94B | $2.02B | $2.18B |
| Net Income Avg | $706M | $925M | $1.07B |
| Low | $649M | $855M | $1.02B |
| High | $763M | $1.02B | $1.17B |
| EPS Avg | $8.53 | $10.84 | $13.13 |
| Low | $7.63 | $10.05 | $12.02 |
| High | $8.97 | $12.04 | $13.74 |
| Analysts (Rev / EPS) | 8 / 7 | 8 / 7 | 5 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.45B | $1.45B | $1.50B | $1.58B | $1.55B | $1.56B | $1.57B | $1.63B |
| Low | $1.41B | $1.40B | $1.45B | $1.53B | $1.50B | $1.51B | $1.52B | $1.58B |
| High | $1.48B | $1.49B | $1.54B | $1.62B | $1.59B | $1.60B | $1.61B | $1.67B |
| EBITDA Avg | $499M | $500M | $516M | $543M | $535M | $538M | $541M | $561M |
| Low | $485M | $484M | $500M | $526M | $518M | $521M | $524M | $543M |
| High | $509M | $513M | $529M | $557M | $549M | $552M | $555M | $575M |
| EBIT Avg | $474M | $475M | $490M | $516M | $508M | $511M | $514M | $533M |
| Low | $461M | $460M | $474M | $500M | $492M | $495M | $497M | $516M |
| High | $483M | $487M | $502M | $529M | $521M | $524M | $527M | $546M |
| Net Income Avg | $198M | $208M | $247M | $252M | $239M | $251M | $275M | $305M |
| Low | $193M | $199M | $237M | $241M | $229M | $241M | $264M | $293M |
| High | $201M | $215M | $255M | $260M | $247M | $259M | $284M | $315M |
| EPS Avg | $2.35 | $2.48 | $2.94 | $3.00 | $2.84 | $2.98 | $3.27 | $3.63 |
| Low | $2.29 | $2.37 | $2.82 | $2.87 | $2.72 | $2.86 | $3.14 | $3.48 |
| High | $2.39 | $2.56 | $3.04 | $3.09 | $2.93 | $3.08 | $3.38 | $3.75 |
| Analysts (Rev / EPS) | 6 / 5 | 5 / 1 | 3 / 1 | 3 / 1 | 3 / 1 | 3 / 1 | 2 / 2 | 2 / 2 |